🇺🇸 FDA
Patent

US 11760786

Chimeric antigen receptors targeting abnormal glycobiology

granted A61KA61K2039/86A61K2239/31

Quick answer

US patent 11760786 (Chimeric antigen receptors targeting abnormal glycobiology) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Sep 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K2039/86, A61K2239/31, A61K2239/38, A61K38/00